ICEC0942, an orally bioavailable selective inhibitor of CDK7 for cancer treatment - Ali, S; Patel, H; Periyasamy, M; Sava, G; Bondke, A; Slafer, BW; Kroll, SHB; Barbazanges, MV; Starkey, RG; Ottaviani, S; Harrod, AE; Aboagye, EO; et al. (Molecular Cancer Therapeutics, 2018)